A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

• Status: Terminated
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is assessing the analgesic efficacy and safety of a new central analgesic in subjects with pain due to diabetic peripheral neuropathy (DPN).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Grünenthal GmbH

Criteria

Inclusion Criteria:

• Symmetrical painful diabetic peripheral neuropathy

Exclusion Criteria:

• History of hypersensitivity, allergy or contraindication to opioids and acetaminophen

• Confounding painful conditions

• Significant vascular disease

• History or risk of seizure

• Chronic disease that might effect drug absorption, distribution, metabolism, or excretion

• Female subjects who are being pregnant or breastfeeding

• Evidence or history of alcohol, medication, or drug abuse